Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:52 PM
Ignite Modification Date:
2025-12-24 @ 7:52 PM
NCT ID:
NCT01664104
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of moderate to severe RA according to revised American College of Rheumatology criteria
* Participants have started tocilizumab treatment according to routine clinical practice within 3 months prior to site opening and still in treatment, as well as participants who began treatment at enrollment
Exclusion Criteria:
* Participants who have started tocilizumab treatment more than 3 months prior to site opening
* Participants who have previously received tocilizumab in a clinical trial setting or for compassionate use
* Participants who have been enrolled in an ongoing clinical trial and/or have received treatment with any investigational drug within 4 weeks prior to study start
* Participants with a history of autoimmune disease or joint inflammatory disease other than RA
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01664104
Study Brief:
Protocol Section:
NCT01664104